Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Greater occipital nerve blockade in frequent migraine and medication-overuse headache
2008-007336-17Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Jul 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in migraine and medication overuse headache (MOH) comparing Diprophos greater occipital nerve blockade with Placebo greater occipital nerve blockade (2 arms). Primary endpoints: Primary endpoint - migraine days reduction and Primary endpoint - hours with moderate or severe headache after withdrawal. Started Jul 2009; status: completed.
02
Drugs
betamethasone dipropionate + betamethasone sodium phosphate
03
Conditions
migrainemedication overuse headache (MOH)
Beyond the preview
Go deeper on 2008-007336-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007336-17.